![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Clinigen Group Plc | LSE:CLIN | London | Ordinary Share | GB00B89J2419 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 925.00 | 924.50 | 925.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCLIN TIDMBARC
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: BARCLAYS CAPITAL SECURITIES LTD (b) Name of offeror/offeree in relation CLINIGEN GROUP PLC to whose relevant securities this form relates: (c) Name of the party to the offer with Triley Bidco Limited (a which exempt newly-formed company indirectly owned by Triton Funds) principal trader is connected (d) Date position held/dealing 07 March 2022 undertaken: (e) In addition to the company in 1(b) NO above, is the exempt principal trader making disclosures in respect of any other party to the offer?
2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: 0.1p ordinary Interests Short Positions Number (%) Number (%) (1) Relevant securities owned and/or controlled: 1,104,939 0.83% 152,188 0.11% (2) Cash-settled derivatives: 26,670 0.02% 429,159 0.32% Stock-settled derivatives (3) (including options) and agreements to purchase/sell: 0 0.00% 0 0.00% TOTAL: 1,131,609 0.85% 581,347 0.44%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of Purchase/sale Total number Highest price Lowest price relevant of per unit per unit security securities paid/received paid/received 0.1p ordinary Purchase 8,598 9.2054 GBP 9.1895 GBP 0.1p ordinary Sale 37,745 9.2100 GBP 9.19 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per relevant description reference unit security securities 0.1p ordinary CFD Decreasing Short 12,452 9.1904 GBP 0.1p ordinary SWAP Opening Long 6,736 9.1911 GBP 0.1p ordinary SWAP Opening Long 8,206 9.2054 GBP 0.1p ordinary SWAP Opening Long 8,375 9.1917 GBP 0.1p ordinary SWAP Opening Long 9,602 9.1921 GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type e.g. Expiry Option relevant description purchasing, securities price American, date money security e.g. call selling, to which per European paid/ option varying option unit etc. received etc. relates per unit
(ii) Exercise
Class of Product Exercising/ Number of Exercise price relevant description exercised securities per unit security e.g. call against option
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of dealing Details Price per unit (if security e.g. subscription, applicable) conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" None
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 8 Mar 2022 Large Holdings Regulatory Contact name: Operations Telephone number: 020 3134 7213
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220308005709/en/
CONTACT:
BARCLAYS PLC
SOURCE: BARCLAYS PLC Copyright Business Wire 2022
(END) Dow Jones Newswires
March 08, 2022 05:57 ET (10:57 GMT)
1 Year Clinigen Chart |
1 Month Clinigen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions